Development of Directly Compressible Co-processed Excipients: Strategies for Development of Directly compressible Co-processed Excipients Used in Tablet

-15% su kodu: ENG15
96,65 
Įprasta kaina: 113,70 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
96,65 
Įprasta kaina: 113,70 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
2025-02-28 113.7000 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 10,00 

Knygos aprašymas

Direct compression method in tableting is widely used due to fewer processing steps, simplified validation, elimination of heat and moisture, economy and improved drug stability. Hence, the current trend in the pharmaceutical industry is to adopt direct compression technology. Most of the drugs do not possess direct compression characteristic. Hence, development of various functionality added excipients (FAEs) to achieve formulations with desired effects is equally important. Excipients with improved functionality can be obtained by developing new chemical excipients, new grades of existing materials and new combination of existing materials. A much broader platform for the manipulation of excipient functionality is provided by co-processing or particle engineering of two or more excipients. The most important approach for controlling price for the excipients is to develop co-processed directly compressible excipients.

Informacija

Autorius: Sanjay Patel, Natvarlal Patel,
Leidėjas: LAP LAMBERT Academic Publishing
Išleidimo metai: 2011
Knygos puslapių skaičius: 208
ISBN-10: 3844398392
ISBN-13: 9783844398397
Formatas: 220 x 150 x 13 mm. Knyga minkštu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „Development of Directly Compressible Co-processed Excipients: Strategies for Development of Directly compressible Co-processed Excipients Used in Tablet“

Būtina įvertinti prekę

Goodreads reviews for „Development of Directly Compressible Co-processed Excipients: Strategies for Development of Directly compressible Co-processed Excipients Used in Tablet“